Magenta Therapeutics Trims R&D, Cuts Workforce
See more from Benzinga
Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy
Read Why Did Evelo Discontinue EDP1867 Atopic Dermatitis Program
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.